Vivanza Biosciences Ltd
Vivanza Biosciences Ltd Live Price Chart
Performance
| Previous Close | ₹ 1.78 |
| High | ₹ 1.74 |
| Volume | 36749 |
| 52W Range | ₹ 1.52 - ₹ 2.72 |
| Open | ₹ 1.7 |
| Low | ₹ 1.7 |
| Market Cap | ₹ 7.52 Cr |
Vivanza Biosciences Ltd Technicals
| 20 Day | ₹ 1.818 |
| 50 Day | ₹ 1.847 |
| 100 Day | ₹ 1.883 |
| 200 Day | ₹ 1.994 |
| 20 Day | ₹ 1.839 |
| 50 Day | ₹ 1.867 |
| 100 Day | ₹ 1.882 |
| 200 Day | ₹ 1.990 |
Vivanza Biosciences Ltd Fundamentals
| ROCE | 6.702 |
| P/E Ratio | 13.310 |
| P/B Ratio | 1.570 |
| Industry P/E | 1.570 |
| Debt to Equity | 51.431 |
| ROE | 8.532 |
| EPS | 0.130 |
| Dividend Yield | 0.000 |
| Book Value | 1.099 |
| Face Value | 1.000 |
Vivanza Biosciences Ltd Financials
| Particulars | Y202603 | Y202503 | Y202403 | Y202303 | Y202203 |
|---|---|---|---|---|---|
| Total Revenue | 112.3404 | 2.9774 | 14.4673 | 14.5939 | 9.9756 |
| Total Expenses | 111.8225 | 3.671 | 14.0384 | 13.9067 | 9.5115 |
| Profit After Tax | 0.375 | -0.6951 | 0.3174 | 0.5691 | 0.4637 |
Vivanza Biosciences Ltd Shareholding Pattern
| Promoter Holdings | 20.020 % |
| FIIs | 0.000 % |
| DIIs | 0.002 % |
| MutualFund | 0.000 % |
| Retail | 73.487 % |
| Others - | 6.492 % |
About Vivanza Biosciences Ltd
Vivanza Biosciences Limited, formerly known as Ivee Injectaa Limited was established in March, 1982 as a Private Limited Company and was later on, converted into a Public Limited Company in May, 1992. Due to recessionary trends which lead to difficult business conditions in year 1999-2000, the parenteral industry suffered a setback and due to this, the name of the Company was changed from Ivee Injectaa Limited to Vivanza Biosciences Limited in 2015. The Company has a 40- years track record of innovation and success in developing oral drug delivery systems. These technologies have been commercialized in numerous products that are marketed around the world. It has expertise in complex oral and topical dose forms including highly potent compounds, modified release products & injections. The Company is focused in commercializing novel and generic pharmaceutical medicines, offering patients better, safe and more accessible medicines. Head quartered in Gujarat, India, the Company came into existence in April 2016 to further spread its wings in global market with global quality pharmaceutical products at competitive pricing system. Company undertook an expansion-cum-diversification programme to increase its capacity from 18 lac pa to 54 lac pa. The Company came out with a public issue of 21,70,000 equity shares of Rs 10 each for cash at par aggregating Rs 217 lac. It is one of the few companies which has facilities for both glass as well as plastic containers. The Com ...
Similar Stocks
| Ambalal Sarabhai Enterprises Ltd Pharmaceuticals | ₹ 43.53 -0.38 (-0.87%) |
| Amrutanjan Health Care Ltd Pharmaceuticals | ₹ 515.05 -1.35 (-0.26%) |
| Astrazeneca Pharma India Ltd Pharmaceuticals | ₹ 7,081.00 -40.1 (-0.56%) |
| Bliss GVS Pharma Ltd Pharmaceuticals | ₹ 587.05 +27.95 (+5%) |
| Abbott India Ltd Pharmaceuticals | ₹ 26,740.00 +361.6 (+1.37%) |
| Cipla Ltd Pharmaceuticals | ₹ 1,418.00 -1.9 (-0.13%) |
FAQs on Vivanza Biosciences Ltd
1. Can I buy Vivanza Biosciences Ltd from PL Capital? ›
2. Does Vivanza Biosciences Ltd pay dividends? ›
3. What is the current share price of Vivanza Biosciences Ltd ? ›
4. What is the 52-week high and low of Vivanza Biosciences Ltd ? ›
Start SIP in Vivanza Biosciences Ltd
Invest systematically in stocks with the
PL Capital app
Are you a new user? Open your account
